Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 10, 2011, Pages 667-670

  Hashad, Doaa I ^a   Hashad, Mohamed Mohie Eldin I ^a   Talaat, Iman M ^a   Ibrahim, Mona A ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE P1; MYOD1 PROTEIN;

ARTICLE; CANCER STAGING; DNA METHYLATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 80054683472     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0262     Document Type: Article

References (24)

1. American Joint Committee on Cancer (2002) Prostrate: in AJCC Cancer Staging Manual, 6th edition. Springer, New York, NY, pp 309-316.
2. Bastian PJ, Ellinger J, Heukamp LC, et al. (2007) Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Eur Urol 51:665-674. (Pubitemid 46097267)
3. Beatty PA (2004) Prostate cancer with low PSA levels. N Engl J Med 351:1802-1803.
4. Bock JL, Klee GG (2004) How sensitive is a prostate specific antigen measurement? How sensitive does it need to be? Arch Pathol Lab Med 128:341-343. (Pubitemid 38316085)
5. Catalona W, Southwick P, Slawin K, et al. (2000) Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. J Urol 56:255-260. (Pubitemid 30495578)
6. Dobosy J, Roberts J, Fu V, Jarrard D (2007) The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol 177:822-883.
7. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hy-permethylation of human cancer. Cancer Res 61:3225-3229.
8. Fradet Y (2009) Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen. Curr Opin Urol 19:243-246.
9. Goessl C, Krause H, Muller M, et al. (2000) Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 60:5941-5945.
10. Goessl C, Muller M, Heicappell R, et al. (2001) DNA-based detection of prostate cancer tissue in urine after prostatic massage. J Urol 58:335-338. (Pubitemid 32816344)
11. Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG (2003) Prostate cancer detection by GSTP1 methylation analysis of post-biopsy urine specimens. Clin Cancer Res 9:2673-2677. (Pubitemid 36842112)
12. Harden S, Sanderson H, Goodman S, et al. (2003) Quantitative GSTP1 methylation and the detection of prostate adenocarci-noma in sextant biopsies. J NCI 95:1634-1637 (Pubitemid 37455931)
13. Henrique R, Jerónimo C (2004) Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 46:660-669. (Pubitemid 39345744)
14. Jerónimo C, Usadel H, Henrique R, et al. (2001) Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93:1747-1752. (Pubitemid 33130264)
15. Jerónimo C, Usadel H, Henrique R, et al. (2002) Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. J Urol 60:1131-1135. (Pubitemid 35447593)
16. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428. (Pubitemid 34587077)
17. Lin X, Tascilar M, Lee W, et al. (2001) GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 159: 1815-1826. (Pubitemid 33062524)
18. Pfister C, Basuyau JP (2005) Current usefulness of free/total PSA ratio in the diagnosis of prostate cancer at an early stage. World J Urol 23:236-342.
19. Phé V, Cussenot O, Rouprêt M (2010) Methylated genes as potential biomarkers in prostate cancer. BJU Int 105:1364-1370.
20. Song J, Stirzaker C, Harrison J, et al. (2002) Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21:1048-1061. (Pubitemid 34174517)
21. Steiner I, Jung K, Schatz P, et al. (2010) Gene promoter methyl-ation and its potential relevance in early prostate cancer diagnosis. Pathobiology 77:260-266.
22. Sunami E, Shinozaki M, Celetia S, et al. (2009) Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem 55:559-567.
23. Thompson IM, Pauler DK, Goodman PJ, et al. (2004) Prevalence of prostate cancer among men with a prostate specific antigen level ≤ or = 4. ng per milliliter, N Engl J Med 350:2239-2246
24. Zanetti R, Tazi MA, Rosso S (2010) New data tells us more about cancer incidence in North Africa. Eur J Cancer 46:462-466.